Emergent Biosolutions
EBS
EBS
224 hedge funds and large institutions have $1.02B invested in Emergent Biosolutions in 2016 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 101 increasing their positions, 60 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $1.22B → $1.02B (-$197M)
84% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $10.6M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
224
Holding in Top 10
–
Calls
$1.67M
Puts
$10.6M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$15.9M | |
| 3 | +$15.4M | |
| 4 |
Morgan Stanley
New York
|
+$14.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.7M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$19.2M | |
| 3 | -$11.2M | |
| 4 |
ICRM
Insight Capital Research & Management
Walnut Creek,
California
|
-$7.39M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$5.1M |